Artificial intelligence-enabled reconstruction of the right ventricular pressure curve using the peak pressure value: a proof-of-concept study

Abstract

Conventional echocardiographic parameters of right ventricular (RV) function are heavily afterload-dependent. Therefore, the incorporation of the RV pressure curve may enable the formulation of new parameters that reflect intrinsic RV function more accurately. Accordingly, we sought to develop an artificial intelligence-based method that can reconstruct the RV pressure curve based on the peak RV pressure.

We invasively acquired RV pressure in 29 heart failure patients before and after the implantation of a left ventricular (LV) assist device. Using these tracings, we trained various machine learning models to reconstruct the RV pressure curve of the entire cardiac cycle solely based on the peak value of the invasively acquired curve. The best-performing model was compared with the performance of two other methods that estimated RV pressure curves based on a reference LV and RV pressure curve, respectively.

Among the evaluated algorithms, the multilayer perceptron (MLP) achieved the best performance with an R² of 0.887 [0.834 – 0.941]. The RV and LV reference curve-based methods achieved R² values of 0.879 [0.815 – 0.943] and 0.636 [0.500 – 0.771], respectively. The MLP and the RV reference curve-based estimation showed good agreement with the invasive RV pressure curves (mean bias: -0.38 mmHg and -0.73 mmHg, respectively), whereas the LV reference curve-based estimation exhibited a high mean bias (+3.93 mmHg).

The proposed method enables the reconstruction of the RV pressure curve, using only the peak value as input. Thus, it may serve as a fundamental component for developing new echocardiographic tools targeting the afterload-adjusted assessment of RV function.

Graphical abstract Key question. Can artificial intelligence be useful in the reconstruction of the right ventricular pressure curve of the entire cardiac cycle using only the peak value as input? Key findings. Multilayer Perceptron predicted instantaneous pressure values with a balanced, low bias throughout the cardiac cycle, even slightly outperforming the reference curve creation methods. Take-home message. Accurate prediction of the right ventricular pressure curve may enable formulation of new echocardiographic parameters targeting the afterload-adjusted assessment of RV function.

LV: left ventricular, PVC: pulmonary valve closure, PVO: pulmonary valve opening, RV: right ventricular, TVC: tricuspid valve closure, TVO: tricuspid valve opening

• Download figure
• Open in new tab

Competing Interest Statement

ZT is a founder and Chief Executive Officer of Argus Cognitive and receives financial compensation for his work. AK is Chief Medical Officer of Argus Cognitive and receives financial compensation for his work. ASz and ASa are employees of Argus Cognitive and receive financial compensation for their work. AF and BKL report personal fees from Argus Cognitive, Inc. MT reports personal fees from CardioSight, Inc., outside the submitted work. All other authors have no competing interests to disclose.

Funding Statement

Project no. RRF-2.3.1-21-2022-00004 (MILAB) has been implemented with the support provided by the European Union. AK is supported by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Duke University Health System Institutional Review Board gave ethical approval for this work (Pro00107652).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes